Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
Year: 2012
Type: article
Study design: Clinical Trial
Source: Leukemia
DOI: 10.1038/leu.2012.134
Institutions: University of Chicago, Jena University Hospital, Friedrich Schiller University Jena, South Australia Pathology, Royal Adelaide Hospital, Royal Liverpool and Broadgreen University Hospital NHS Trust, Royal Liverpool University Hospital, Institut Bergonié, The Catholic University of Korea Seoul St. Mary's Hospital, Catholic University of Korea, Sarah Cannon Research Institute, Sarah Cannon, The University of Tokyo, Hospital Ramos Mejía, Novartis (United States), Novartis (Switzerland), University of Turin, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2072834954
